| Company Name: |
S.Z. PhyStandard Bio-Tech. Co., Ltd.
|
| Tel: |
0755-4000505016 13380397412 |
| Email: |
3001272453@qq.com |
| Products Intro: |
Product Name:Dabigatran Etexilate iMpurity E
CAS:1415506-19-2
Purity:99% HPLC Package:10mg;25mg;50mg;100mg
|
| Company Name: |
Wuxi Minglu Medicine technology Co.,Ltd.
|
| Tel: |
0510-88726693 |
| Email: |
3204601684@qq.com |
| Products Intro: |
Product Name:Dabigatran Etexilate impurity E
CAS:1415506-19-2
Purity:0.98 Package:10mg、25mg、50mg、100mg
|
|
| | Dabigatran Etexilate iMpurity E Basic information |
| Product Name: | Dabigatran Etexilate iMpurity E | | Synonyms: | Dabigatran Etexilate iMpurity E;Dabigatran Ester Impurity E;β-Alanine, N-[[2-[[[4-[(E)-amino[[(hexyloxy)carbonyl]imino]methyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-;(E)-3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoic acidQ: What is
(E)-3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoic acid Q: What is the CAS Number of
(E)-3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoic acid;(E)-3-(2-(((4-(N'-((Hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoic acid (Dabigatran Impurity）;(E)-3-(2-(((4-(N'-((Hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoic acid? (Dabigatran Impurity） | | CAS: | 1415506-19-2 | | MF: | C32H37N7O5 | | MW: | 599.69 | | EINECS: | | | Product Categories: | | | Mol File: | 1415506-19-2.mol |  |
| | Dabigatran Etexilate iMpurity E Chemical Properties |
| density | 1.29±0.1 g/cm3(Predicted) | | pka | 4.17±0.10(Predicted) |
| | Dabigatran Etexilate iMpurity E Usage And Synthesis |
| | Dabigatran Etexilate iMpurity E Preparation Products And Raw materials |
|